3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33692538 | Vismodegib improves quality of life in patients with periocular locally advanced basal cell carcinoma: subgroup analysis, STEVIE trial. | 2022 Feb | 1 |
2 | 35210571 | The initial rate of tumour response to vismodegib treatment, can predict a complete response outcome for periocular LA-BCC. | 2022 Feb 24 | 1 |
3 | 32407451 | Outcomes of Vismodegib for Periocular Locally Advanced Basal Cell Carcinoma From an Open-label Trial. | 2020 Jul 1 | 2 |